The OCT4-GFP reporter cell line was created as described previously47 (link). Cells were expanded on mitomycin C-treated MEF (mouse embryonic fibroblast) feeder cells with Knockout DMEM containing 10% KSR (knockout serum replacement), 10% human plasmanate (Talecris Biotherapeutics), 1% NEAA (non-essential amino acids), 1% penicillin/streptomycin, 1% Gluta-MAX, and 55 μM 2-mercaptoethanol47 (link). 30 ng/mL of bFGF (basic fibroblast growth factor, Life Technologies) was added daily into the growth medium and cells were passaged using Accutase (Millipore) at ~80% confluency.